Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Apr 5:7:97-103.
doi: 10.1016/j.amsu.2016.03.039. eCollection 2016 May.

Hepatocyte growth factor, hepatocyte growth factor activator and arginine in a rat fulminant colitis model

Nathan P Zwintscher  1 , Puja M Shah  2 , Shashikumar K Salgar  3 , Christopher R Newton  4 , Justin A Maykel  5 , Ahmed Samy  6 , Murad Jabir  6 , Scott R Steele  6
Affiliations

Hepatocyte growth factor, hepatocyte growth factor activator and arginine in a rat fulminant colitis model

Nathan P Zwintscher et al. Ann Med Surg (Lond). .

Abstract

Introduction: Dextran sodium sulfate (DSS) is commonly used to induce a murine fulminant colitis model. Hepatocyte growth factor (HGF) has been shown to decrease the symptoms of inflammatory bowel disease (IBD) but the effect of its activator, HGFA, is not well characterized. Arginine reduces effects of oxidative stress but its effect on IBD is not well known. The primary aim is to determine whether HGF and HGFA, or arginine will decrease IBD symptoms such as pain and diarrhea in a DSS-induced fulminant colitis murine model.

Methods: A severe colitis was induced in young, male Fischer 344 rats with 4% (w/v) DSS oral solution for seven days; rats were sacrificed on day 10. Rats were divided into five groups of 8 animals: control, HGF (700 mcg/kg/dose), HGF and HGFA (10 mcg/dose), HGF and arginine, and high dose HGF (2800 mcg/kg/dose). Main clinical outcomes were pain, diarrhea and weight loss. Blinded pathologists scored the terminal ileum and distal colon.

Results: DSS reliably induced severe active colitis in 90% of animals (n = 36/40). There were no differences in injury scores between control and treatment animals. HGF led to 1.38 fewer days in pain (p = 0.036), while arginine led to 1.88 fewer days of diarrhea (P = 0.017) compared to controls. 88% of HGFA-treated rats started regaining weight (P < 0.001).

Discussion/conclusion: Although treatment was unable to reverse fulminant disease, HGF and arginine were associated with decreased days of pain and diarrhea. These clinical interventions may reduce associated symptoms for severe IBD patients, even when urgent surgical intervention remains the only viable option.

Keywords: Fulminant colitis; Inflammatory bowel disease.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Hemotoxylin and eosin stained sections (40×) of colon from dextran sodium sulfate (DSS)-induced colitis in rats.
Fig. 2
Fig. 2
Average rat weight by day and treatment.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Turner D., Levine A., Escher J.C. Management of pediatric ulcerative colitis: joint ECCO and ESPGHAN evidence-based consensus guidelines. J. Pediatr. Gastroenterol. Nutr. 2012;55(3):340–361. - PubMed
    1. Kugathasan S., Dubinsky M.C., Keljo D. Severe colitis in children. J. Pediatr. Gastroenterol. Nutr. 2005;41(4):375–385. http://www.ncbi.nlm.nih.gov/pubmed/16205502 (accessed 12.10.15) - PubMed
    1. Cima R.R. Timing and indications for colectomy in chronic ulcerative colitis: surgical consideration. Dig. Dis. 2010;28(3):501–507. - PubMed
    1. Kirsner J.B. Historical origins of medical and surgical therapy of inflammatory bowel disease. Lancet (Lond. Engl.) 1998;352(9136):1303–1305. - PubMed
    1. Cohen J.L., Strong S.A., Hyman N.H. Practice parameters for the surgical treatment of ulcerative colitis. Dis. Colon Rectum. 2005;48(11):1997–2009. - PubMed